000			01815 a2200517 4500
005			20250515130846.0
264		0	_c20090112
008			200901s 0 0 eng d
022			_a1476-5462
024	7		_a10.1038/gt.2008.120 _2doi
040			_aNLM _beng _cNLM
100	1		_aByrne, M J
245	0	0	_aRecirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals. _h[electronic resource]
260			_bGene therapy _cDec 2008
300			_a1550-7 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aCardiac Pacing, Artificial
650	0	4	_aCoronary Circulation
650	0	4	_aDependovirus _xgenetics
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aEchocardiography
650	0	4	_aGene Expression
650	0	4	_aGenetic Therapy _xmethods
650	0	4	_aGenetic Vectors _xadministration & dosage
650	0	4	_aHeart Failure _xmetabolism
650	0	4	_aLiver _xvirology
650	0	4	_aLung _xvirology
650	0	4	_aModels, Animal
650	0	4	_aMyocardium _xmetabolism
650	0	4	_aPolymerase Chain Reaction _xmethods
650	0	4	_aRNA, Messenger _xanalysis
650	0	4	_aRandom Allocation
650	0	4	_aSarcoplasmic Reticulum Calcium-Transporting ATPases _xblood
650	0	4	_aSheep
650	0	4	_aTime
650	0	4	_aTransduction, Genetic _xmethods
650	0	4	_aTransgenes
700	1		_aPower, J M
700	1		_aPreovolos, A
700	1		_aMariani, J A
700	1		_aHajjar, R J
700	1		_aKaye, D M
773	0		_tGene therapy _gvol. 15 _gno. 23 _gp. 1550-7
856	4	0	_uhttps://doi.org/10.1038/gt.2008.120 _zAvailable from publisher's website
999			_c18130414 _d18130414